InsidersTradesSigma
Follow the MicroPort NeuroScientific Corporation share price and the full directors' dealings record of the company, a listed issuer based in Hong Kong. Shares are quoted on the HK market, under the authority of HKEX. Operating in the Health Care sector, MicroPort NeuroScientific Corporation has logged 2 insider filings. Market capitalisation: €5bn. The latest transaction was filed on 20 April 2026 (Purchase). Among the most active insiders: Zhang Jie. All data is accessible without an account.
2
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
4Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 6,457 of 29,064 companies
65.5
score / 100
Value48
Quality83
FCF yld3.1%
Earn yld3.7%
EV/EBITDA17.2x
ROE11%
Gross mgn73%
Net mgn23%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 20 April 2026
Declarations2 total
247,000 sharesShareXHKGHKEX:DA20260408E00422
2 of 2 declarations
关于 MicroPort NeuroScientific Corporation
MicroPort NeuroScientific Corporation 是一家专注于开发用于治疗神经系统疾病的医疗设备的公司。该公司在香港证券交易所上市。